An Open, Single-Dose, Phase I, 4-Period Partly Crossover Study in Healthy Men or Women to Assess Relative Bioavailability of Oral Administration of AZD1981 Via Tablets Compared With Suspension and Basic Systemic Pharmacokinetic Parameters After Intravenous Administration.
Latest Information Update: 18 Dec 2009